On January 10th, King's College London announced on its official website that a new study found that the use of nicotine pouches has doubled in the past four years, reaching 5.4%.
A new study conducted by the Institute of Psychiatry, Psychology and Neuroscience (IoPPN) at King's College London in collaboration with the Action on Smoking and Health (ASH) organization has found that approximately 1% of UK adults (18 and over) and teenagers (11-18 years old) are currently using nicotine pouches. The study was published in the journal Nicotine and Tobacco Research.
Researchers analyzed data from the UK Adult Smokeless Survey from 2020 to 2024 and the UK Youth Smokeless Survey from 2024 to evaluate whether respondents have ever used or are currently using nicotine pouches, as well as other sociodemographic information. The data showed that the proportion of UK adults who had ever used nicotine pouches doubled to 5.4% between 2020 and 2024, but only 1% of respondents said they were currently using them. Among adolescents, 1.2% of respondents reported currently using them.
This research was published in the "Tobacco and E-Cigarette Act" as it entered the committee review stage in the Lower House. The bill specifies the legal age for the sale of nicotine pouches as 18 years old, prohibits related advertising, and allows for government regulation of the ingredients, brands, and displays of the products.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
